AGREEMENTAgreement • November 22nd, 1999 • Maxygen Inc • Services-commercial physical & biological research
Contract Type FiledNovember 22nd, 1999 Company Industry
BETWEENCollaboration Agreement • November 22nd, 1999 • Maxygen Inc • Services-commercial physical & biological research • California
Contract Type FiledNovember 22nd, 1999 Company Industry Jurisdiction
BETWEENCollaborative Research and License Agreement • November 22nd, 1999 • Maxygen Inc • Services-commercial physical & biological research • California
Contract Type FiledNovember 22nd, 1999 Company Industry Jurisdiction
EXHIBIT 1.1 Maxygen, Inc. Common Stock par value $0.0001 per share Underwriting Agreement ----------------------Underwriting Agreement • November 22nd, 1999 • Maxygen Inc • Services-commercial physical & biological research • New York
Contract Type FiledNovember 22nd, 1999 Company Industry Jurisdiction
The term "Development Program" shall mean research and development activities within the areas outlined in Exhibit A attached hereto, as --------- supplemented or amended from time to time according to mutual written agreement between the Parties. Cf....License and Collaboration Agreement • November 22nd, 1999 • Maxygen Inc • Services-commercial physical & biological research • New York
Contract Type FiledNovember 22nd, 1999 Company Industry Jurisdiction
Exhibit 10.3 Affymax/Maxygen Technology Transfer Agreement By and among Affymax Technologies N.V. and Glaxo Group Limited (collectively "the Glaxo Wellcome Companies"), and Maxygen, Inc. 1.0 INTRODUCTION 1.1 The parties to this Agreement are: Affymax...Maxygen Inc • November 22nd, 1999 • Services-commercial physical & biological research • California
Company FiledNovember 22nd, 1999 Industry Jurisdiction